Financial News · Live Terminal

Page 27 of 39

Travelers Companies Insider Sold Shares Worth $869,980, According to a Recent SEC Filing

Diane Kurtzman, Executive Vice President & Chief Human Resources Officer, on April 20, 2026, sold 2,867 shares in Travelers Companies (TRV) for $869,980. Following the Form 4 filing with the SEC, Kurtzman has control over a total of 5,298 common shares of the company, with 5,298 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/86312/000008631226000117/xslF345X05/form4.xml

Financial News · Live Terminal

Travelers Companies Insider Sold Shares Worth $869,980, According to a Recent SEC Filing

Novanta Insider Sold Shares Worth $845,325, According to a Recent SEC Filing

Equitable Holdings Insider Sold Shares Worth $1,652,640, According to a Recent SEC Filing

Travelers Companies Insider Sold Shares Worth $1,956,549, According to a Recent SEC Filing

Arteris Insider Sold Shares Worth $1,994,354, According to a Recent SEC Filing

Arteris Insider Sold Shares Worth $442,168, According to a Recent SEC Filing

Incyte Insider Sold Shares Worth $1,801,366, According to a Recent SEC Filing

Goldman Sachs Group Insider Sold Shares Worth $1,024,895, According to a Recent SEC Filing

Credit Acceptance Insider Sold Shares Worth $1,576,894, According to a Recent SEC Filing

Badger Meter Insider Bought Shares Worth $258,573, According to a Recent SEC Filing

Davey Tree Expert Insider Sold Shares Worth $740,122, According to a Recent SEC Filing

Pagseguro Digital Insider Sold Shares Worth $2,252,000, According to a Recent SEC Filing

Darden Restaurants Insider Sold Shares Worth $731,837, According to a Recent SEC Filing

Marvell Technology Insider Sold Shares Worth $1,355,000, According to a Recent SEC Filing

United Therapeutics Insider Sold Shares Worth $5,778,607, According to a Recent SEC Filing

United Therapeutics Insider Sold Shares Worth $5,489,424, According to a Recent SEC Filing

Kailera Therapeutics Insider Bought Shares Worth $134,375,008, According to a Recent SEC Filing

Kailera Therapeutics Insider Bought Shares Worth $25,000,000, According to a Recent SEC Filing

Scholar Rock Holding Insider Sold Shares Worth $1,517,723, According to a Recent SEC Filing

Robinhood Markets Insider Sold Shares Worth $4,946,061, According to a Recent SEC Filing

Travelers Companies Insider Sold Shares Worth $869,980, According to a Recent SEC Filing

Novanta Insider Sold Shares Worth $845,325, According to a Recent SEC Filing

Equitable Holdings Insider Sold Shares Worth $1,652,640, According to a Recent SEC Filing

Travelers Companies Insider Sold Shares Worth $1,956,549, According to a Recent SEC Filing

Arteris Insider Sold Shares Worth $1,994,354, According to a Recent SEC Filing

Arteris Insider Sold Shares Worth $442,168, According to a Recent SEC Filing

Incyte Insider Sold Shares Worth $1,801,366, According to a Recent SEC Filing

Goldman Sachs Group Insider Sold Shares Worth $1,024,895, According to a Recent SEC Filing

Credit Acceptance Insider Sold Shares Worth $1,576,894, According to a Recent SEC Filing

Badger Meter Insider Bought Shares Worth $258,573, According to a Recent SEC Filing

Davey Tree Expert Insider Sold Shares Worth $740,122, According to a Recent SEC Filing

Pagseguro Digital Insider Sold Shares Worth $2,252,000, According to a Recent SEC Filing

Darden Restaurants Insider Sold Shares Worth $731,837, According to a Recent SEC Filing

Marvell Technology Insider Sold Shares Worth $1,355,000, According to a Recent SEC Filing

United Therapeutics Insider Sold Shares Worth $5,778,607, According to a Recent SEC Filing

United Therapeutics Insider Sold Shares Worth $5,489,424, According to a Recent SEC Filing

Kailera Therapeutics Insider Bought Shares Worth $134,375,008, According to a Recent SEC Filing

Kailera Therapeutics Insider Bought Shares Worth $25,000,000, According to a Recent SEC Filing

Scholar Rock Holding Insider Sold Shares Worth $1,517,723, According to a Recent SEC Filing

Robinhood Markets Insider Sold Shares Worth $4,946,061, According to a Recent SEC Filing